Quality

NovaMatrix® manufacture PRONOVA™ sodium alginate in our facilities in Norway. We operate according to GMP guidelines and ISO standards; ISO 9001:2015 and ISO 13485:2016. Furthermore NovaMatrix holds the Manufacturing License for API’s issued by the Norwegian Medicine Agency (NOMA).

Our Sodium Hyaluronate ultrapure products are produced by our partner, Kikkoman Biochemifa Company, Japan, under GMP guidelines; the Pharmaceutical Affairs Law of Japan, ICH Q7 and ISO standards; ISO 9001:2015 and ISO 14001:2004.